Zymeworks Inc.

ZYME

$29.90

-3.70%

N/A-$1.15

Healthcare

Biotechnology

NASDAQ

Active Trading

Zymeworks Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying, advancing, and bringing to market biological therapies aimed ...

Insider Transactions of ZYME

Acquisitions (A)

Since Apr 9, 2026

Disposals (D)

Since Apr 9, 2026

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Insider Trading Snapshot

Date	Executive	Title	Security	Side	Shares	Price
Jul 6, 2026	Hollywood Mark	officer: EVP & Chief Operating Officer	Common Stock	A	939	$22.22
May 13, 2026	Schneider Paul R	officer: EVP, General Counsel	Stock Option (Right to Buy)	A	178,000	$24.57
May 13, 2026	Schneider Paul R	officer: EVP, General Counsel	Restricted Stock Unit	A	119,000	—
May 13, 2026	Schneider Paul R	officer: EVP, General Counsel	No securities are beneficially owned	—	0	—
Apr 9, 2026	Schayowitz Adam	officer: See Remarks	Performance Stock Unit	A	76,000	—

Insider Trading Snapshot

Acquisitions (A)

Disposals (D)

Total Shares Bought

683,939

Total Shares Sold

Monthly Insider Activity

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Transactions by Title - Shares

X-axis: shares, sorted by total shares desc

Transactions by Title - Counts

X-axis: counts, sorted by A+D counts desc

Key People: Buy/Sell Activity and Price

Schneider Paul R

officer: EVP, General Counsel • 3 txns

Schayowitz Adam

officer: See Remarks • 3 txns

Platshon Scott

officer: EVP, Chief Business Officer • 3 txns

Hollywood Mark

officer: EVP & Chief Operating Officer • 1 txns

Transactions Table

Date	Executive	Title	Security	Side	Shares	Price	Value
Jul 6, 2026	Hollywood Mark	officer: EVP & Chief Operating Officer	Common Stock	A	939	$22.22	$20,864.58
May 13, 2026	Schneider Paul R	officer: EVP, General Counsel	Stock Option (Right to Buy)	A	178,000	$24.57	$4,373,460.00
May 13, 2026	Schneider Paul R	officer: EVP, General Counsel	Restricted Stock Unit	A	119,000	—	—
May 13, 2026	Schneider Paul R	officer: EVP, General Counsel	No securities are beneficially owned	—	0	—	—
Apr 9, 2026	Schayowitz Adam	officer: See Remarks	Performance Stock Unit	A	76,000	—	—
Apr 9, 2026	Schayowitz Adam	officer: See Remarks	Stock Option (Right to Buy)	A	70,000	$27.35	$1,914,500.00
Apr 9, 2026	Schayowitz Adam	officer: See Remarks	Restricted Stock Unit	A	47,000	—	—
Apr 9, 2026	Platshon Scott	officer: EVP, Chief Business Officer	Performance Stock Unit	A	76,000	—	—
Apr 9, 2026	Platshon Scott	officer: EVP, Chief Business Officer	Stock Option (Right to Buy)	A	70,000	$27.35	$1,914,500.00
Apr 9, 2026	Platshon Scott	officer: EVP, Chief Business Officer	Restricted Stock Unit	A	47,000	—	—

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer